Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TREK-1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TREK-1 is a protein involved in neurodegeneration research. Key relationships include: regulates, modulates, expressed in. Associated with Corticosteroid-Induced Ocular Hypertension, Influenza A-Induced Lung Injury, OHT. Connected to 26 entities in the SciDEX knowledge graph.
| Gene Symbol | TREK |
| Function | Trek 1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. |
| GeneCards | TREK |
| Human Protein Atlas | TREK |
| Associated Diseases | ALS, Corticosteroid-Induced Ocular Hypertension |
| Known Drugs/Compounds | ML-402, Glucocorticoids, Spadin, BL1249, ML335, riluzole |
| Interactions | AND, TRPV4, PIEZO, PIEZO1, TRPC1, CXCL10 |
| KG Connections | 111 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
TREK_1["<b>TREK-1</b>"]
Conventional_Outflow(["Conventional Outflow"])
TREK_1 -->|"regulates"| Conventional_Outflow
Intraocular_Pressure["Intraocular Pressure"]
TREK_1 -->|"regulates"| Intraocular_Pressure
Adipocyte_Differentiation(["Adipocyte Differentiation"])
TREK_1 -->|"regulates"| Adipocyte_Differentiation
Lipid_Accumulation["Lipid Accumulation"]
TREK_1 -->|"regulates"| Lipid_Accumulation
Influenza_A_Induced_Lung_Injury{"Influenza A-Induced Lung Injury"}
TREK_1 -->|"protects against"| Influenza_A_Induced_Lung_Injury
Adipocytes["Adipocytes"]
TREK_1 -->|"expressed in"| Adipocytes
Trabecular_Meshwork["Trabecular Meshwork"]
TREK_1 -->|"expressed in"| Trabecular_Meshwork
Ca2__Influx(["Ca2+ Influx"])
TREK_1 -->|"inhibits"| Ca2__Influx
Cell_Membrane_Potential_Hyperpolarizatio(["Cell Membrane Potential Hyperpolarization"])
TREK_1 -->|"mediates"| Cell_Membrane_Potential_Hyperpolarizatio
Corticosteroid_Induced_Ocular_Hypertensi{"Corticosteroid-Induced Ocular Hypertension"}
TREK_1 -->|"contributes to"| Corticosteroid_Induced_Ocular_Hypertensi
Cell_Membrane_Electrical_Potential["Cell Membrane Electrical Potential"]
TREK_1 -->|"modulates"| Cell_Membrane_Electrical_Potential
Inflammatory_Response(["Inflammatory Response"])
TREK_1 -->|"modulates"| Inflammatory_Response
Spadin["Spadin"]
Spadin -->|"inhibits"| TREK_1
BL1249["BL1249"]
BL1249 -->|"activates"| TREK_1
ML335["ML335"]
ML335 -->|"activates"| TREK_1
Mechanosensation(["Mechanosensation"])
Mechanosensation -->|"involved in"| TREK_1
Glucocorticoids["Glucocorticoids"]
Glucocorticoids -->|"modulates"| TREK_1
KCNK2["KCNK2"]
KCNK2 -->|"encodes"| TREK_1
RPL31["RPL31"]
RPL31 -->|"interacts with"| TREK_1
MBD1["MBD1"]
MBD1 -->|"binds"| TREK_1
ML_402["ML-402"]
ML_402 -->|"activates"| TREK_1
PrPC["PrPC"]
PrPC -->|"interacts with"| TREK_1
style TREK_1 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Conventional Outflow | regulates | process | 0.95 |
| Intraocular Pressure | regulates | phenotype | 0.95 |
| Adipocyte Differentiation | regulates | process | 0.95 |
| Lipid Accumulation | regulates | phenotype | 0.95 |
| Influenza A-Induced Lung Injury | protects_against | disease | 0.95 |
| Corticosteroid-Induced Ocular Hypertension | associated_with | disease | 0.92 |
| Adipocyte Differentiation | inhibits | process | 0.92 |
| Adipocytes | expressed_in | cell_type | 0.90 |
| Glucocorticoids | associated_with | drug | 0.90 |
| Lipid Accumulation | inhibits | phenotype | 0.90 |
| Aqueous Humor Outflow | regulates | process | 0.90 |
| Ca2+ Influx | modulates | mechanism | 0.88 |
| Trabecular Meshwork | expressed_in | cell_type | 0.85 |
| Ca2+ Influx | inhibits | process | 0.85 |
| Cell Membrane Potential Hyperpolarization | mediates | process | 0.85 |
| Cell Membrane Potential | regulates | mechanism | 0.85 |
| Corticosteroid-Induced Ocular Hypertension | contributes_to | disease | 0.80 |
| Cell Membrane Electrical Potential | modulates | phenotype | 0.80 |
| Inflammatory Response | modulates | process | 0.80 |
| Influenza A virus | protects_against | virus | 0.80 |
| OUTFLOW_FACILITY | regulates | phenotype | 0.72 |
| IOP | regulates | phenotype | 0.72 |
| TM_CELLS | expressed_in | cell_type | 0.72 |
| Hypertension | activates | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| astrocytes | expressed_in | cell_type | 0.65 |
| AND | activates | gene | 0.60 |
| TRPV4 | activates | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| PIEZO | activates | gene | 0.60 |
| PIEZO1 | activates | gene | 0.60 |
| KCNK2 | expressed_in | gene | 0.60 |
| TRPC1 | activates | gene | 0.60 |
| CXCL10 | activates | gene | 0.60 |
| TNF-Α | activates | gene | 0.60 |
| Nf-Κb | activates | pathway | 0.60 |
| KCNK2 | activates | gene | 0.60 |
| IL-6 | activates | gene | 0.60 |
| Epithelial | activates | cell_type | 0.60 |
| KCNK2 | associated_with | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| FSP1 | activates | gene | 0.60 |
| Rb | activates | protein | 0.60 |
| Fus | expressed_in | protein | 0.60 |
| App | activates | protein | 0.60 |
| App | inhibits | protein | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Spadin | inhibits | drug | 0.90 |
| BL1249 | activates | compound | 0.90 |
| ML335 | activates | compound | 0.90 |
| Mechanosensation | involved_in | process | 0.85 |
| Glucocorticoids | modulates | drug | 0.85 |
| KCNK2 | encodes | gene | 0.80 |
| RPL31 | interacts_with | gene | 0.80 |
| MBD1 | binds | gene | 0.80 |
| dexamethasone | inhibits | drug | 0.80 |
| ML-402 | activates | drug | 0.72 |
| PrPC | interacts_with | protein | 0.70 |
| Dexamethasone | regulates | drug | 0.70 |
| GENES | activates | gene | 0.60 |
| FSP1 | activates | gene | 0.60 |
| KCNK2 | expressed_in | gene | 0.60 |
| PIEZO1 | activates | gene | 0.60 |
| TRPC1 | activates | gene | 0.60 |
| KCNK2 | associated_with | gene | 0.60 |
| TRPV4 | activates | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| IL-6 | activates | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| KCNK10 | activates | gene | 0.60 |
| PIEZO | activates | gene | 0.60 |
| TNF-Α | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| KCNK2 | activates | gene | 0.60 |
| KCNK2 | implicated_in | gene | 0.55 |
| CREB | activates | gene | 0.55 |
| BDNF | biomarker_for | gene | 0.55 |
| AQP4 | associated_with | gene | 0.55 |
| AQP4 | activates | gene | 0.55 |
| AQP4 | regulates | gene | 0.55 |
| riluzole | targets | drug | 0.55 |
| AQP4 | expressed_in | gene | 0.55 |
| GFAP | activates | gene | 0.55 |
| S100B | activates | gene | 0.55 |
| FSP1 | co_discussed | gene | 0.50 |
| GENES | co_discussed | gene | 0.50 |
| KCNK2 | co_discussed | gene | 0.50 |
| PIEZO1 | co_discussed | gene | 0.50 |
| CXCL10 | activates | gene | 0.50 |
| KCNK2 | regulates | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu | 0.437 | neurodegeneration | Perivascular spaces and glymphatic clear |
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Novel function of TREK-1 in regulating adipocyte differentiation and lipid accum [PMID:40057491] | Kim A, Jung S, Kim Y, Jung J, Lee S, Lee | Cell Death Dis | 2025 | 1 |
| Mechano- and Glucocorticoid-Sensitive TREK-1 Channels Regulate Conventional Outf [PMID:41268978] | Redmon SN, Yarishkin O, Rudzitis CN, Lak | Invest Ophthalmol Vis Sci | 2025 | 1 |
| Activation of TREK-1 (K(2P)2.1) potassium channels protects against influenza A- [PMID:36410022] | Zyrianova T, Lopez B, Zou K, Gu C, Pham | Am J Physiol Lung Cell Mol Phy | 2023 | 1 |
| Multiethnic meta-analysis identifies ancestry-specific and cross-ancestry loci f [PMID:30061609] | Wyss AB, Sofer T, Lee MK, Terzikhan N, N | Nat Commun | 2018 | 1 |
| Temperature sensitivity of two-pore (K2P) potassium channels. [PMID:25366235] | Schneider ER, Anderson EO, Gracheva EO, | Curr Top Membr | 2014 | 1 |
| TREK-king the blood-brain-barrier. [PMID:24557892] | Bittner S, Ruck T, Fernández-Orth J, Meu | J Neuroimmune Pharmacol | 2014 | 1 |
| The Glymphatic-Venous Axis in Brain Clearance Failure: Aquaporin-4 Dysfunction, [PMID:41226584] | ["Costea D", "Dobrin N", "Tataru C", "To | International journal of molec | 2025 | 0 |
| Genetic Insights into Brain Morphology: a Genome-Wide Association Study of Corti [PMID:40167904] | ["Kim N", "Chowdhury N", "Buetow K", "Th | Neuroinformatics | 2025 | 0 |
| Calcium-dependent activation of TREK-1 and TREK-2 background potassium channels [PMID:41457157] | Baukál D, Pergel E, Debreczeni D, Horvát | Scientific reports | 2025 | 0 |
| The two-pore domain potassium channel KCNK5 deteriorates outcome in ischemic neu [PMID:25315980] | Göb E, Bittner S, Bobak N, Kraft P, Göbe | Pflugers Archiv : European jou | 2015 | 0 |
| Systemic mastocytosis in the elderly. [PMID:23436294] | ["Butterfield J", "Weiler C"] | American journal of hematology | 2013 | 0 |
| Carbon catabolite repression regulates amino acid permeases in Saccharomyces cer [PMID:16407266] | ["Peter G", "D\u00fcring L", "Ahmed A"] | The Journal of biological chem | 2006 | 0 |